QNTM Quantum BioPharma Corp Gross Return on Sales

Quantum BioPharma Ltd is currently undergoing a deep transformation, pivoting toward IT platforms and bio-solutions. Gross marginal profit on GURU.Markets reflects the dynamics of this process, where the value of 0.00 characterizes this level. A mix of CRO services and functional nutrition provides stability, although small market capitalization and volatility within the cannabis sector create critical financial risks.
Comprehensive metric breakdowns and analytics for Quantum BioPharma Ltd (QNTM)

The stability of Quantum BioPharma Ltd (QNTM) during its business model transition toward IT platforms depends on the efficiency of direct cost controls. This metric determines the profit margin after deducting the cost of goods sold, allowing investors to assess operating profitability and the company's ability to service its debt, which makes the gross margin percentage a key tool for monitoring the asset's financial recovery.